Eyeonics Inc. said Wednesday that its sales for the quarter ending Sept. 30 jumped 127% from the year ago period in the runup to its initial public offering.
The Aliso Viejo maker of replacement lenses for cataract patients said its revenue totaled $10 million, up from $4.4 million in the same period last year.
Eyeonics filed in July to raise up to $86.5 million in its IPO, but hasn’t yet set a date for the offering. Eyeonics’ shares are set to trade on the Nasdaq under the ticker “EYON.”
Eyeonics’ lead product, the Crystalens, has now been implanted in more than 85,000 eyes worldwide.
